Janux Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 11.19 M | $273.48 M | 0.00% | 18.08% |
| FMR LLC | 11/13/2025 | 9.06 M | $221.33 M | 1.88% | 14.63% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 4.70 M | $114.99 M | 5.40% | 7.59% |
| BLACKROCK, INC. | 11/12/2025 | 3.73 M | $91.19 M | 9.64% | 6.03% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 2.92 M | $71.37 M | 0.00% | 4.72% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 2.78 M | $67.82 M | 9.90% | 4.48% |
| VANGUARD GROUP INC | 11/07/2025 | 2.42 M | $59.07 M | 10.40% | 3.90% |
| STATE STREET CORP | 11/14/2025 | 1.89 M | $46.23 M | 36.26% | 3.06% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.77 M | $43.16 M | 45.92% | 2.85% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.71 M | $41.80 M | -20.23% | 2.76% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.27 M | $30.93 M | -29.43% | 2.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.08 M | $26.49 M | 20.12% | 1.75% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.03 M | $25.10 M | -17.31% | 1.66% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 972.69 K | $23.77 M | 100.00% | 1.57% |
| READYSTATE ASSET MANAGEMENT LP | 11/07/2025 | 960.38 K | $23.47 M | 37.99% | 1.55% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 935.00 K | $22.85 M | -6.50% | 1.51% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 887.76 K | $21.70 M | -16.97% | 1.43% |
| PROSIGHT MANAGEMENT, LP | 11/14/2025 | 865.35 K | $21.15 M | 1.34% | 1.40% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 850.00 K | $20.77 M | -43.33% | 1.37% |
| CITADEL ADVISORS LLC | 11/14/2025 | 802.78 K | $19.62 M | -34.79% | 1.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 701.60 K | $17.15 M | 42.50% | 1.13% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 700.00 K | $17.11 M | 250.00% | 1.13% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 655.11 K | $16.01 M | 87.98% | 1.06% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 639.70 K | $15.63 M | 42.98% | 1.03% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 614.28 K | $15.01 M | 0.00% | 0.99% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 594.83 K | $14.54 M | -11.42% | 0.96% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 500.00 K | $12.22 M | 0.00% | 0.81% |
| MORGAN STANLEY | 11/14/2025 | 495.64 K | $12.11 M | 56.98% | 0.80% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 493.45 K | $12.06 M | -42.58% | 0.80% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 424.85 K | $10.38 M | 64.24% | 0.69% |
| UBS GROUP AG | 11/13/2025 | 390.36 K | $9.54 M | 33.44% | 0.63% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 11/12/2025 | 376.50 K | $9.20 M | 0.00% | 0.61% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 354.54 K | $8.67 M | 18.43% | 0.57% |
| NORTHERN TRUST CORP | 11/14/2025 | 354.11 K | $8.65 M | 3.59% | 0.57% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 351.03 K | $8.58 M | 465.38% | 0.57% |
| ABRDN PLC | 11/07/2025 | 345.48 K | $8.44 M | 21.10% | 0.56% |
| ROYAL BANK OF CANADA | 11/14/2025 | 331.58 K | $8.10 M | -0.65% | 0.54% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 298.88 K | $7.08 M | 21.04% | 0.48% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 292.69 K | $7.15 M | 0.00% | 0.47% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 257.53 K | $6.29 M | 81.64% | 0.42% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 256.06 K | $6.26 M | 0.18% | 0.41% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 240.63 K | $5.88 M | 73.54% | 0.39% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 210.37 K | $5.14 M | 0.05% | 0.34% |
| JPMORGAN CHASE & CO | 11/26/2025 | 209.18 K | $5.11 M | -15.46% | 0.34% |
| JUMP FINANCIAL, LLC | 11/13/2025 | 179.70 K | $4.39 M | -21.33% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 169.14 K | $4.13 M | -26.46% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 167.10 K | $4.08 M | 63.34% | 0.27% |
| BARCLAYS PLC | 11/12/2025 | 144.02 K | $3.52 M | 8.83% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 120.47 K | $2.94 M | 5.03% | 0.19% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 110.85 K | $2.71 M | -55.28% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Janux Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 207 institutional investors and hedge funds held shares of Janux Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 11.19 M
FMR LLC: 9.06 M
JANUS HENDERSON GROUP PLC: 4.7 M
BlackRock, Inc.: 3.73 M
Paradigm Biocapital Advisors LP: 2.92 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.78 M
105.24% of Janux Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 68.15 M shares in the last 24 months. This purchase volume represents approximately $1.64 B in transactions.